Diabetic Neuropathy Study Group: Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study (vol 24, pg 1776, 2001)

被引：0
|
作者：
Hotta, N
Toyota, T
Matsuoka, K
Shigeta, Y
Kikkawa, R
Kaneko, T
Takahashi, A
Sugimura, K
Koike, Y
Ishii, J
Sakamoto, N
机构：
来源：
DIABETES CARE | 2002年 / 25卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：413 / 414
页数：2
相关论文
共 50 条
  • [1] Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy - A 52-week multicenter placebo-controlled double-blind parallel group study
    Hotta, N
    Toyota, T
    Matsuoka, K
    Shigeta, Y
    Kikkawa, R
    Kaneko, T
    Takahashi, A
    Sugimura, K
    Koike, Y
    Ishii, J
    Sakamoto, N
    DIABETES CARE, 2001, 24 (10) : 1776 - 1782
  • [2] Effects of fidarestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: A 52-week placebo-controlled double-blind study
    Hotta, N
    Ishii, J
    Sakamoto, N
    DIABETES, 2000, 49 : A35 - A35
  • [3] A double-blind placebo-controlled study of the efficacy of cerenin on diabetic neuropathy
    Thajeb, P
    Lin, MS
    Chen, PH
    NEUROLOGY, 1996, 46 (02) : 1060 - 1060
  • [4] Analgesic Efficacy of Fulranumab in Patients with Painful Diabetic Peripheral Neuropathy in a Randomized, Placebo-Controlled, Double-Blind Study
    Wang, Hao
    Romano, Gary
    Frustaci, Mary Ellen
    Sanga, Panna
    Ness, Seth
    Russell, Lucille
    Fedgchin, Margaret
    Kelly, Kathleen
    Thipphawong, John
    NEUROLOGY, 2013, 80
  • [5] Lacosamide in painful diabetic peripheral neuropathy - A phase 2 double-blind placebo-controlled study
    Rauck, Richard L.
    Shaibani, Aziz
    Biton, Victor
    Simpson, Jqff
    Koch, Brigitte
    CLINICAL JOURNAL OF PAIN, 2007, 23 (02): : 150 - 158
  • [6] Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy
    Kessler, John A.
    Smith, A. Gordon
    Cha, Bong-Soo
    Choi, Sung Hee
    Wymer, James
    Shaibani, Aziz
    Ajroud-Driss, Senda
    Vinik, Aaron
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (05): : 465 - 478
  • [7] Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomised, double-blind, placebo-controlled study
    Stoker, M.
    Katz, N.
    Van, J.
    Snijder, R.
    Jacobs, H.
    Long, S.
    Schregardus, D.
    Lambourg, B.
    Robinson-Papp, J.
    Simpson, D.
    DIABETOLOGIA, 2015, 58 : S32 - S32
  • [8] Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study
    Simpson, David M.
    Robinson-Papp, Jessica
    Van, Joanna
    Stoker, Malcolm
    Jacobs, Helene
    Snijder, Robert J.
    Schregardus, Diederik S.
    Long, Stephen K.
    Lambourg, Bruno
    Katz, Nathaniel
    JOURNAL OF PAIN, 2017, 18 (01): : 42 - 53
  • [9] LX9211 in individuals with painful diabetic peripheral neuropathy: results from a randomised, double-blind, placebo-controlled, parallel-group, multicentre study
    Pop-Busui, R.
    Patel, A.
    Sang, C.
    Granowitz, C.
    Banks, P.
    Pierce, P.
    Sun, F.
    Gopinathan, S.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S17 - S18
  • [10] EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR, EPALRESTAT, ON DIABETIC NEUROPATHY - CLINICAL BENEFIT AND INDICATION FOR THE DRUG ASSESSED FROM THE RESULTS OF A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY
    GOTO, Y
    HOTTA, N
    SHIGETA, Y
    SAKAMOTO, N
    KIKKAWA, R
    BIOMEDICINE & PHARMACOTHERAPY, 1995, 49 (06) : 269 - 277
12345